Laboratory Evaluation of Antiphospholipid Syndrome: Is There a Role for Specific Noncriteria Antiphospholipid Antibody Tests?

被引:5
作者
Heikal, Nahla [1 ,2 ]
Martins, Thomas B. [1 ]
White, Sandra K. [2 ]
Willis, Rohan [4 ]
Branch, D. Ware [3 ,5 ]
Schmidt, Robert L. [1 ,2 ]
Tebo, Anne E. [1 ,2 ]
机构
[1] Univ Utah, Sch Med, ARUP Inst Clin & Expt Pathol, Salt Lake City, UT 84112 USA
[2] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84112 USA
[3] Univ Utah, Sch Med, Div Maternal Fetal Med, Salt Lake City, UT USA
[4] Univ Texas Med Branch, Dept Internal Med, Div Rheumatol, Galveston, TX 77555 USA
[5] Intermt Healthcare, Salt Lake City, UT USA
关键词
Antiphospholipid antibodies; Antiphospholipid syndrome; Diagnostic significance; GLYCOPROTEIN I ANTIBODIES; LUPUS ANTICOAGULANT; PHOSPHATIDYLSERINE/PROTHROMBIN ANTIBODIES; RISK STRATIFICATION; ANTICARDIOLIPIN; BETA-2-GLYCOPROTEIN-I; GUIDELINES; DIAGNOSIS; UPDATE; ASSAYS;
D O I
10.1093/ajcp/aqz085
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Objectives: Anti-beta(2) glycoprotein I domain I (anti-domain I) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies are present in patients with antiphospholipid syndrome (APS); however, their use in evaluation remains unclear. Methods: Diagnostic attributes of lupus anticoagulant (LAC), anti-domain I IgG, anti-cardiolipin, anti-beta(2) glycoprotein I (anti-beta(2)GPI), and aPS/PT IgG and IgM antibodies were assessed in 216 patients evaluated for APS. Results: LAC had the best odds ratio (OR, 14.2) while that for anti-domain 1 IgG was comparable to anti-beta(2)GPI IgG (OR, 8.3 vs 9.4) but higher than all others. Significant correlations were observed for thrombosis (P = .03) and pregnancy-related morbidity (P = .001) with anti-domain IgG and for any thrombosis with aPS/PT IgG (P = .006). Use of noncriteria antiphospholipid with or without criteria markers did not significantly increase the probability to diagnose APS. Conclusions: Noncriteria tests can contribute to diagnosis and stratification of APS but do not improve diagnostic yield. Optimal strategies for implementation require prospective investigation.
引用
收藏
页码:638 / 646
页数:9
相关论文
共 25 条
[1]   New autoantigens in the antiphospholipid syndrome [J].
Alessandri, Cristiano ;
Conti, Fabrizio ;
Pendolino, Monica ;
Mancini, Riccardo ;
Valesini, Guido .
AUTOIMMUNITY REVIEWS, 2011, 10 (10) :609-616
[2]  
Amengual O, 1996, BRIT J RHEUMATOL, V35, P1239
[3]   Antiprothrombin antibody: why do we need more assays? [J].
Atsumi, T. ;
Koike, T. .
LUPUS, 2010, 19 (04) :436-439
[4]   The challenges of lupus anticoagulants [J].
Chighizola, Cecilia Beatrice ;
Raschi, Elena ;
Banzato, Alessandra ;
Borghi, Maria Orietta ;
Pengo, Vittorio ;
Meroni, Pier Luigi .
EXPERT REVIEW OF HEMATOLOGY, 2016, 9 (04) :389-400
[5]   Role of anti-domain 1-β2glycoprotein I antibodies in the diagnosis and risk stratification of antiphospholipid syndrome [J].
De Craemer, A. -S. ;
Musial, J. ;
Devreese, K. M. J. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 (09) :1779-1787
[6]   Testing for Antiphospholipid antibodies with Solid Phase Assays: guidance from the SSC of the ISTH [J].
Devreese, K. M. J. ;
Pierangeli, S. S. ;
De Laat, B. ;
Tripodi, A. ;
Atsumi, T. ;
Ortel, T. L. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 (05) :792-795
[7]   Variability and diagnostic utility of antiphospholipid antibodies including lupus anticoagulants [J].
Favaloro, E. J. .
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2013, 35 (03) :269-274
[8]   Laboratory evaluation of anti-phospholipid syndrome: a preliminary prospective study of phosphatidylserine/prothrombin antibodies in an at-risk patient cohort [J].
Heikal, N. M. ;
Jaskowski, T. D. ;
Malmberg, E. ;
Lakos, G. ;
Branch, D. W. ;
Tebo, A. E. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2015, 180 (02) :218-226
[9]  
Horbach DA, 1996, THROMB HAEMOSTASIS, V76, P916
[10]   Relationship between antiphosphatidylserine/prothrombin and conventional antiphospholipid antibodies in primary antiphospholipid syndrome [J].
Hoxha, Ariela ;
Ruffatti, Amelia ;
Mattia, Elena ;
Meneghel, Lauro ;
Tonello, Marta ;
Salvan, Elisa ;
Pengo, Vittorio ;
Punzi, Leonardo .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2015, 53 (08) :1265-1270